Personal Home Page

http://www.acrc.uams.edu/directory/bio.asp?id=124

Articles in Scholarly Journals [Incomplete List]

1. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells
   The Prostate, vol. 68, no. 4, pp. 408–417, 2008
2. Reply to the letter to the Editor: “N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis”
   International Journal of Cancer, vol. 121, no. 7, pp. 1637–1639, 2007
3. A variant of the Cockayne syndrome B geneERCC6 confers risk of lung cancer
   Human Mutation, vol. 29, no. 1, pp. 113–122, 2007
4. Sulfotransferase 4A1
   The International Journal of Biochemistry & Cell Biology, 2007
5. The UGT2B17 gene deletion polymorphism and risk of prostate cancerA case–control study in Caucasians
   Cancer Detection and Prevention, vol. 31, no. 4, pp. 310–315, 2007
6. Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells?
   Archives of Biochemistry and Biophysics, vol. 464, no. 2, pp. 169–175, 2007
7. Processed meat intake, CYP2A6 activity and risk of colorectal adenoma
   Carcinogenesis, vol. 28, no. 6, pp. 1210–1216, 2007
8. DNA supercoiling suppresses real-time PCR: a new approach to the quantification of mitochondrial DNA damage and repair
   Nucleic Acids Research, vol. 35, no. 4, pp. 1377–1388, 2007
9. Cystine-Glutamate Transporter SLC7A11 Mediates Resistance to Geldanamycin but Not to 17-(Allylamino)-17-demethoxygeldanamycin
   Molecular Pharmacology, vol. 72, no. 6, pp. 1637–1646, 2007
10. Hormone-Metabolizing Genotypes: An Alternate Interpretation
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 9, pp. 1911–1911, 2007
11. Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype
    Pharmacogenetics and Genomics, vol. 16, no. 5, pp. 359–367, 2006
12. Associations between Catalase Phenotype and Genotype: Modification by Epidemiologic Factors
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 6, pp. 1217–1222, 2006
13. Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 8, pp. 1473–1478, 2006
14. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition
    Proceedings of the National Academy of Sciences, vol. 103, no. 24, pp. 9256–9261, 2006
15. CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl
    International Journal of Cancer, vol. 119, no. 11, pp. 2520–2526, 2006
16. Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients
    Breast Cancer Research and Treatment, vol. 91, no. 3, pp. 249–258, 2005
17. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine
    International Journal of Cancer, vol. 118, no. 1, pp. 161–168, 2005
18. Expression of cytochromes P450 and glutathioneS-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogensvia acetyl-coA-, PAPS- and ATP-dependent pathways
    International Journal of Cancer, vol. 117, no. 1, pp. 8–13, 2005
19. Identification of Functional Genetic Variants in and Their Association With Risk of Esophageal Cancer
    Gastroenterology, vol. 129, no. 2, pp. 565–576, 2005
20. Human Alpha Class Glutathione S‐Transferases: Genetic Polymorphism, Expression, and Susceptibility to Disease
    Methods in Enzymology, vol. 401, pp. 9–42, 2005
21. Chemical Research in Toxicology, vol. 18, no. 4, pp. 692–699, 2005
22. Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon
    Journal of Chemical Neuroanatomy, vol. 29, no. 1, pp. 71–80, 2005
23. Dietary Intake of Heterocyclic Amines and Benzo(a)Pyrene: Associations with Pancreatic Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 9, pp. 2261–2265, 2005
24. CYP3A43 Pro340Ala Polymorphism and Prostate Cancer Risk in African Americans and Caucasians
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 5, pp. 1257–1261, 2005
25. Common genetic polymorphisms in the 5???-flanking Region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity
    Pharmacogenetics and Genomics, vol. 15, no. 7, pp. 465–473, 2005
26. A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 7, pp. 1832–1836, 2005
27. Human glutathione S-transferase A2 polymorphisms
    Pharmacogenetics, vol. 14, no. 1, pp. 35–44, 2004
28. Mitochondrial Mutagenesis and Oxidative Stress in Human Prostate Cancer
    Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis & Ecotoxicology Reviews, vol. 22, no. 1, pp. 1–12, 2004
29. Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians
    Cancer Epidemiology Biomarkers & Prevention, vol. 13, no. 2, pp. 270–276, 2004
30. Examination of Human Tissue Cytosols for Expression of Sulfotransferase Isoform 1A2 (SULT1A2) Using a SULT1A2-Specific Antibody
    Molecular Pharmacology, vol. 67, no. 2, pp. 394–399, 2004
31. Chemical Research in Toxicology, vol. 17, no. 12, pp. 1659–1666, 2004
32. Chemical Research in Toxicology, vol. 17, no. 4, pp. 529–536, 2004
33. Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism
    Lung Cancer, vol. 44, no. 3, pp. 281–286, 2004
34. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepaticN-acetyltransferase and glutathioneS-transferase activities
    Environmental and Molecular Mutagenesis, vol. 44, no. 4, pp. 265–276, 2004
35. Increased transcriptional activity of theCYP3A4*1B promoter variant
    Environmental and Molecular Mutagenesis, vol. 42, no. 4, pp. 299–305, 2003
36. Association between a glutathioneS-transferase A1 promoter polymorphism and survival after breast cancer treatment
    International Journal of Cancer, vol. 103, no. 6, pp. 810–814, 2003
37. Variation in cyclooxygenase expression levels within the colorectum
    Molecular Carcinogenesis, vol. 37, no. 1, pp. 25–31, 2003
38. Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP–DNA adduct formation
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 523-524, pp. 193–200, 2003
39. Chemical Research in Toxicology, vol. 16, no. 1, pp. 66–73, 2003
40. Chemical Research in Toxicology, vol. 16, no. 9, pp. 1162–1173, 2003
41. Chemical Research in Toxicology, vol. 16, no. 3, pp. 432–432, 2003
42. Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis
    Carcinogenesis, vol. 24, no. 9, pp. 1481–1487, 2003
43. Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2
    Carcinogenesis, vol. 24, no. 3, pp. 583–587, 2003
44. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke
    Carcinogenesis, vol. 24, no. 4, pp. 719–725, 2003
45. A new clue to glaucoma pathogenesis
    The American Journal of Medicine, vol. 114, no. 8, pp. 697–698, 2003
46. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas
    Pharmacogenetics, vol. 12, no. 2, pp. 145–150, 2002
47. Basic or applied, it's the interaction that counts
    Nature, vol. 417, no. 6885, Article ID 417117a, 1 pages, 2002
48. Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue
    Lung Cancer, vol. 38, no. 1, pp. 15–21, 2002
49. Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer
    Toxicology, vol. 181-182, pp. 83–87, 2002
50. Meat intake and cooking techniques: associations with pancreatic cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506-507, pp. 225–231, 2002
51. Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F1 neonatal mouse
    Cancer Letters, vol. 185, no. 1, pp. 13–19, 2002
52. Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals
    Archives of Biochemistry and Biophysics, vol. 403, no. 2, pp. 270–276, 2002
53. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506-507, pp. 175–185, 2002
54. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells
    Environmental and Molecular Mutagenesis, vol. 39, no. 2-3, pp. 134–142, 2002
55. Carcinogen-DNA adducts in human breast epithelial cells
    Environmental and Molecular Mutagenesis, vol. 39, no. 2-3, pp. 184–192, 2002
56. Frequency ofCYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population
    International Journal of Cancer, vol. 95, no. 2, pp. 96–101, 2001
57. Concluding remarks: symposium on Genetic Susceptibility to Environmental Toxicants
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 482, no. 1-2, pp. 111–113, 2001
58. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 482, no. 1-2, pp. 57–69, 2001
59. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 482, no. 1-2, pp. 3–10, 2001
60. Specific site methylation in the 5'-flanking region of CYP1A2 Interindividual differences in human livers
    Life Sciences, vol. 69, no. 7, pp. 839–845, 2001
61. In Vitro Human Tissue Models in Risk Assessment: Report of a Consensus-Building Workshop
    Toxicological Sciences, vol. 59, no. 1, pp. 17–36, 2001
62. Carcinogen substrate specificity of human COX-1 and COX-2
    Carcinogenesis, vol. 22, no. 1, pp. 5–10, 2001
63. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression
    Pharmacogenetics, vol. 11, no. 8, pp. 663–669, 2001
64. METABOLIC ACTIVATION CAPACITY OF NEONATAL MICE IN RELATION TO THE NEONATAL MOUSE TUMORIGENICITY BIOASSAY1*
    Drug Metabolism Reviews, vol. 32, no. 2, pp. 241–266, 2000
65. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline
    Carcinogenesis, vol. 21, no. 6, pp. 1213–1219, 2000
66. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline
    Carcinogenesis, vol. 21, no. 7, pp. 1347–1354, 2000
67. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls
    Pharmacogenetics, vol. 10, no. 9, pp. 761–766, 2000
68. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol
    Pharmacogenetics, vol. 10, no. 9, pp. 789–797, 2000
69. Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide
    Cancer Letters, vol. 156, no. 2, pp. 167–175, 2000
70. Cancer Therapy and Polymorphisms of Cytochromes P450
    Clinical Chemistry and Laboratory Medicine, vol. 38, no. 9, pp. 883–887, 2000
71. Effect of Waterborne Potassium Permanganate Exposure on Manganese Content in Liver and Axial Muscle of Channel Catfish
    Journal of Aquatic Animal Health, vol. 11, no. 3, p. 305, 1999
72. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method
    Pharmacogenetics, vol. 9, no. 3, pp. 327–332, 1999
73. Chemopreventive Effects of Tea Extracts and Various Components on Human Pancreatic and Prostate Tumor Cells In Vitro
    Nutrition and Cancer, vol. 35, no. 1, pp. 80–86, 1999
74. Chemical Research in Toxicology, vol. 12, no. 10, pp. 906–916, 1999
75. Cell Biology and Toxicology, vol. 15, no. 6, pp. 389–394, 1999
76. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative
    Cancer Letters, vol. 143, no. 2, pp. 167–171, 1999
77. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved
    Carcinogenesis, vol. 20, no. 6, pp. 1107–1114, 1999
78. Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases
    Carcinogenesis, vol. 20, no. 6, pp. 991–995, 1999
79. CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice
    Carcinogenesis, vol. 20, no. 9, pp. 1825–1830, 1999
80. Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 424, no. 1-2, pp. 263–274, 1999
81. The effects of phytoestrogens on human pancreatic tumor cells in vitro
    Cancer Letters, vol. 142, no. 1, pp. 111–119, 1999
82. An FDA Review of Sulfamethazine Toxicity
    Regulatory Toxicology and Pharmacology, vol. 30, no. 3, pp. 217–222, 1999
83. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines
    Chemico-Biological Interactions, vol. 109, no. 1-3, pp. 237–248, 1998
84. Letter to the editor
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 405, no. 1, pp. 111–112, 1998
85. Comparison of DNA adduct levels associated with oxidative stress in human pancreas
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 405, no. 2, pp. 125–133, 1998
86. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells
    Carcinogenesis, vol. 19, no. 11, pp. 2049–2053, 1998
87. Metabolic activation of methyl-hydroxylated derivatives of 7,12- dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase
    Carcinogenesis, vol. 19, no. 6, pp. 1071–1076, 1998
88. Use of polyclonal antibodies against carcinogen–DNA adducts in analysis of carcinogenesis
    Toxicology Letters, vol. 102-103, no. 1-2, pp. 441–446, 1998
89. Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G-->C transversions at a unique dG(8-ABP) lesion in single-stranded DNA
    Carcinogenesis, vol. 18, no. 12, pp. 2403–2414, 1997
90. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes
    Carcinogenesis, vol. 18, no. 4, pp. 851–854, 1997
91. Metabolic activation of aromatic amines by human pancreas
    Carcinogenesis, vol. 18, no. 5, pp. 1085–1092, 1997
92. Effect of Waterborne Copper Sulfate Exposure on Copper Content in Liver and Axial Muscle of Channel Catfish
    Journal of Aquatic Animal Health, vol. 9, no. 2, p. 144, 1997
93. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 115–122, 1997
94. Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 135–142, 1997
95. Neonatal Mouse Assay for Tumorigenicity: Alternative to the Chronic Rodent Bioassay,
    Regulatory Toxicology and Pharmacology, vol. 26, no. 2, pp. 230–240, 1997
96. Metabolic differences and their impact on human disease Sulfotransferase and colorectal cancer
    Environmental Toxicology and Pharmacology, vol. 4, no. 3-4, pp. 277–281, 1997
97. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl–DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 378, no. 1-2, pp. 97–112, 1997
98. Cell Proliferation in Rat Forestomach Following Oral Administration of Styrene Oxide
    Fundamental and Applied Toxicology, vol. 30, no. 1, pp. 67–74, 1996
99. SHORT COMMUNICATION: Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro
    Carcinogenesis, vol. 17, no. 4, pp. 889–892, 1996
100. Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa
     Carcinogenesis, vol. 17, no. 9, pp. 2081–2083, 1996
101. Inhibitory effect of caloric restriction on tumorigenicity induced by 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in the CD1 newborn mouse bioassay
     Cancer Letters, vol. 104, no. 2, pp. 133–136, 1996
102. Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations
     Pharmacogenetics, vol. 5, no. Special Issue, pp. S108–S117, 1995
103. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis
     Toxicology Letters, vol. 82-83, pp. 627–632, 1995
104. Formation of Malondialdehyde-Modified 2'-Deoxyguanosinyl Adduct from Metabolism of Chloral Hydrate by Mouse Liver Microsomes
     Biochemical and Biophysical Research Communications, vol. 216, no. 3, pp. 1110–1117, 1995
105. Quantitative Immunohistochemical Analysis of 4-Aminobiphenyl-DNA in Cultured Cells and Mice: Comparison to Gas Chromatography/Mass Spectroscopy Analysis
     Chemical Research in Toxicology, vol. 8, no. 5, pp. 747–752, 1995
106. Chemical Research in Toxicology, vol. 7, no. 6, pp. 733–739, 1994
107. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
     Nature, vol. 369, no. 6476, Article ID 369154a0, 2 pages, 1994
108. Expression of monomorphic and polymorphic N-acetyltransferases in human colon
     Biochemical Pharmacology, vol. 47, no. 5, pp. 914–917, 1994
109. Hepatic Metabolism of Chloral Hydrate to Free Radical(s) and Induction of Lipid Peroxidation
     Biochemical and Biophysical Research Communications, vol. 204, no. 2, pp. 937–943, 1994
110. Study of sodium saccharin co-carcinogenicity in the rat
     Food and Chemical Toxicology, vol. 32, no. 3, pp. 207–213, 1994
111. Plasma proteins as early biomarkers of exposure to carcinogenic aromatic amines
     Chemico-Biological Interactions, vol. 93, no. 3, pp. 221–234, 1994
112. Biochemical Individuality and Its Implications for Drug and Carcinogen Metabolism: Recent Insights from Acetyltransferase and Cytochrome P4501a2 Phenotyping and Genotyping in Humans
     Drug Metabolism Reviews, vol. 26, no. 1, pp. 37–46, 1994
113. Role of acetylation in colorectal cancer
     Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 290, no. 1, pp. 35–42, 1993
114. Metabolic activation, DNA adducts, and H-ras mutations in human neoplastic and non-neoplastic laryngeal tissue
     Journal of Cellular Biochemistry, vol. 53, no. S17F, pp. 129–137, 1993
115. Chemical Research in Toxicology, vol. 6, no. 4, pp. 480–485, 1993
116. Inducibility of human cytochromes P-450 primarily involved in the activation of chemical carcinogens
     Chemosphere, vol. 25, no. 1-2, pp. 201–204, 1992
117. Chemical Research in Toxicology, vol. 5, no. 5, pp. 691–697, 1992
118. Detection of human DNA–carcinogen adducts
     Nature, vol. 360, no. 6400, Article ID 360189a0, 1 pages, 1992
119. Chemical Research in Toxicology, vol. 5, no. 4, pp. 479–490, 1992
120. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells
     Biochemical and Biophysical Research Communications, vol. 185, no. 3, pp. 839–844, 1992
121. Mutagenicity of nitro-polycyclic aromatic hydrocarbons with the nitro substituent situated at the longest molecular axis
     Mutation Research Letters, vol. 283, no. 1, pp. 45–52, 1992
122. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse
     Cancer Letters, vol. 62, no. 3, pp. 205–209, 1992
123. Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies
     Toxicology Letters, vol. 64-65, pp. 469–475, 1992
124. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
     Pharmacogenetics, vol. 2, no. 3, pp. 116–127, 1992